Products Categories
| CAS No.: | 99011-02-6 |
|---|---|
| Name: | Imiquimod |
| Article Data: | 25 |
| Cas Database | |
| Molecular Structure: | |
|
|
|
| Formula: | C14H16N4 |
| Molecular Weight: | 240.308 |
| Synonyms: | Aldara;4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline;1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-; |
| EINECS: | 619-387-8 |
| Density: | 1.28 g/cm3 |
| Melting Point: | 292-294 °C |
| Boiling Point: | 456.7 °C at 760 mmHg |
| Flash Point: | 230 °C |
| Solubility: | Soluble in dimethyl sulfoxide and dimethyl formamide. Slightly soluble in water. Insoluble in ethanol. |
| Appearance: | White to off white crystalline powder |
| Hazard Symbols: |
 T,
 Xi
|
| Risk Codes: | 25-36/37/38 |
| Safety: | 26-45-36/37/39-27 |
| Transport Information: | UN 2811 6.1/PG 3 |
| PSA: | 56.73000 |
| LogP: | 3.40390 |
- 99-02-5Ethanone,1-(3-chlorophenyl)-
- 99026-77-4L-Alanine,glycyl-L-lysylglycyl-L-alanylglycyl-L-leucyl-L-seryl-L-leucyl-L-seryl-L-arginyl-L-phenylalanyl-L-seryl-L-tryptophylglycyl-(9CI)
- 99026-78-5GLY-LYS-GLY-ARG-GLY-LEU-SER-LEU-SER-ALA-PHE-SER-TRP-GLY-ALA
- 99026-79-6Butanedioic acid,1-[2-(2-chloro-5-methylphenoxy)-1-[[(1,1-dimethylethyl)amino]methyl]ethyl]4-[2-[(1-oxohexadecyl)oxy]-1-[[(1-oxohexadecyl)oxy]methyl]ethyl] ester, hydrochloride(1:1)
- 99026-99-0Limonexic acid
- 99035-52-6Acetic acid, butyl esters, manuf. of, distn. residues
- 99035-53-7Acetic acid, 2-ethoxyethyl ester, manuf. of, distn. residues
- 99035-55-9ALUMINUM OXIDE-TECH
- 99035-78-6C.I. Disperse Red 343
- 99-03-6Ethanone,1-(3-aminophenyl)-
- 201030-96-8
4-Hydrazino-1-(2-methylpropyl)-1H-imidazo [4,5-c]quinoline
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| With hydrogenchloride; sodium formate; palladium 10% on activated carbon In water for 84h; Product distribution / selectivity; Heating / reflux; | 98% |
| Stage #1: 4-Hydrazino-1-(2-methylpropyl)-1H-imidazo [4,5-c]quinoline With hydrogenchloride; sodium formate; palladium 10% on activated carbon In water for 84h; Heating / reflux; Stage #2: With hydrogenchloride In water at 20℃; Stage #3: With ammonia In water at 20℃; Product distribution / selectivity; | 98% |
- 132206-92-9
4-chloro-1H-imidazo[4,5-c]-quinoline
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| Stage #1: formamide With potassium tert-butylate In dimethyl sulfoxide for 0.5h; Stage #2: 4-chloro-1H-imidazo[4,5-c]-quinoline In dimethyl sulfoxide at 105℃; for 2h; Stage #3: With hydrogenchloride In water; dimethyl sulfoxide pH=8; Product distribution / selectivity; | 98% |
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| With ethylenediamine In water at 70 - 95℃; for 4h; | 91.8% |
| Stage #1: N-(1-isobutyl-1H-imidazo[4,5-c]quinolin-4-yl)-phthalimide With hydrazine In water at 70℃; Stage #2: With 2,4,4-trimethylpentan-1-ol In water at 94 - 95℃; for 5h; Stage #3: In methanol; water at 60℃; for 0.25h; Heating / reflux; | 63.3% |
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| With ammonia; water In methanol Product distribution / selectivity; | 90% |
- 960254-02-8
5-(2-aminophenyl)-1-(2-methylpropyl)-1H-imidazole-4-carbonitrile
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| With sodium amide In toluene at 20 - 100℃; for 2h; | 90% |
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| Stage #1: 4-amino-1-isobutyl-1H-imidazo-[4,5-c]-quinoline maleate In methanol; water at 75℃; for 0.5h; Stage #2: With ammonia In water | 89.7% |
| With ammonia; water In methanol Product distribution / selectivity; | 89.7% |
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| With ammonia; water In methanol Product distribution / selectivity; | 88% |
- 896106-15-3
4-iodo-1-isobutyl-1H-imidazo-[4,5-c]-quinoline
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| With ammonia In methanol at 150 - 155℃; Autoclave (ca. 20 kg pressure); | 86% |
| With ammonia In methanol at 150 - 155℃; under 14711.4 Torr; Product distribution / selectivity; Autoclave; | 86% |
- 99010-64-7
4-Chloro-1-(2-methylpropyl)-1H-imidazo[4,5-c]quinoline
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| With ammonia In dimethyl sulfoxide at 20 - 150℃; under 1875.19 - 3750.38 Torr; for 6 - 12h; Product distribution / selectivity; | 85.7% |
| With ammonia at 150℃; for 7h; | 82% |
| With ammonia; formamide at 145℃; for 20 - 25h; Product distribution / selectivity; | 78% |
- 99011-02-6
imiqimod
| Conditions | Yield |
|---|---|
| Stage #1: imiquimod hydrochloride With sodium hydrogensulfide; pyrographite In water at 85 - 90℃; for 0.333333h; Stage #2: With ammonium hydroxide In water at 20 - 80℃; Purification / work up; | 80.5% |
| With sodium hydroxide In water at 20℃; for 0.5h; Product distribution / selectivity; |
- 12069-69-1Cupric carbonate basic
- 211915-84-33-[[[2-[[(4-Cyanophenyl)amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]pyridin-2-ylamino]propionic acid ethyl ester
- 171228-49-2D-threo-Pentitol,2,5-anhydro-1,3,4-trideoxy-2-C-(2,4-difluorophenyl)-4-[[4-[4-[4-[1-[(1S,2S)-1-ethyl-2-hydroxypropyl]-1,5-dihydro-5-oxo-4H-1,2,4-triazol-4-yl]phenyl]-1-piperazinyl]phenoxy]methyl]-1-(1H-1,2,4-triazol-1-yl)-
- 101831-37-2Diclazuril
- 13951-70-716alpha-Hydroxyprednisolone
- 136310-93-53-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane,7-[(2-hydroxy-2,2-di-2-thienylacetyl)oxy]-9,9-dimethyl-, bromide (1:1), (1a,2b,4b,5a,7b)-
- 719-59-52-Amino-5-chlorobenzophenone
- 32449-92-6D(+)-Glucurono-3,6-lactone
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Chemistry
Molecular Structure of Imiquimod (CAS NO.99011-02-6):
.png)
IUPAC Name: 1-(2-methylpropyl)imidazo[4,5-c]quinolin-4-amine
Empirical Formula: C14H16N4
Molecular Weight: 240.3036
H bond acceptors: 4
H bond donors: 2
Freely Rotating Bonds: 2
Polar Surface Area: 33.95 Å2
Index of Refraction: 1.681
Molar Refractivity: 71.02 cm3
Molar Volume: 187.7 cm3
Surface Tension: 48.8 dyne/cm
Density: 1.28 g/cm3
Flash Point: 230 °C
Enthalpy of Vaporization: 71.67 kJ/mol
Boiling Point: 456.7 °C at 760 mmHg
Vapour Pressure: 1.58E-08 mmHg at 25°C
Melting point: 292-294°C
Stability: Incompatible with strong oxidizing agents
InChl
InChI=1/C14H16N4/c1-9(2)7-18-8-16-12-13(18)10-5-3-4-6-11(10)17-14(12)15/h3-6,8-9H,7H2,1-2H3,(H2,15,17)
Smiles
c12c3c(nc(c1ncn2CC(C)C)N)cccc3
Product Categories: Active Pharmaceutical Ingredients; Intermediates & Fine Chemicals; Pharmaceuticals
History
The original FDA approval was on February 27, 1997, FDA Application No. (NDA) 020723, by 3M.
Uses
Imiquimod (CAS NO.99011-02-6) is a prescription medication that acts as an immune response modifier. Imiquimod is approved to treat actinic keratosis, superficial basal cell carcinoma, and external genital warts. It has also been tested for treatment of molluscum contagiosum, vulvar intraepithelial neoplasia, common warts that have proven difficult to treat and vaginal intraepithelial neoplasia.Outstanding cosmetic result has resulted from the treatment of both large superficial basal cell carcinoma and squamous cell carcinoma in-situ, but the morbidity and discomfort of the treatment can be severe. Focal recurrence of tumor has been seen after imiquimod treatment, but appear to be amenable to surgical excision.
Imiquimod can also cause subclinical lesions to become visible. This unmasking effect is felt to be of clinical benefit as lesions that may have otherwise have been missed are being treated. Photographs of actinic keratosis and basal cell carcinomas before, during and after treatment show the unmasking of subclinical disease.
Safety Profile
Safety Information about Imiquimod (CAS NO.99011-02-6):
Hazard Codes: 
T,
Xi
Risk Statements: 25-36/37/38
R25 :Toxic if swallowed.
R36/37/38:Irritating to eyes, respiratory system and skin.
Safety Statements: 26-45-36/37/39-27
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S45:In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection.
S27:Take off immediately all contaminated clothing.
RIDADR: UN 2811 6.1/PG 3
Adverse side effects have been reported, in some cases serious and systemic, resulting in the revision of warning labels.
Specification
Imiquimod , with CAS number of 99011-02-6, can be called 4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline ; 1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)- ; 1H-Imidazo[4,5-c]quinolin-4-amine, 1-(2-methylpropyl)- . It is a white to off white crystalline powder.